IL6 and colitis: Animal model studies of immune-related enterocolitis further showed that the IL-6 levels in intestinal tissues could initiate irAEs related colitis, while IL-6 inhibition simultaneously ameliorated neurotoxicity and enhanced antitumor immunity (28).